Ledger.Open graph →
SEC Form D · filed March 14, 2018

Prevail Therapeutics Inc

Offering
$65.0M
Sold
$57.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Carl Gordon · SAN FRANCISCO, CADirectorPeter Thompson · Seattle, WADirectorMona Ashiya · NEW YORK, NYDirectorCarl Gordon · Encinitas, CADirectorAsa Abeliovich · NEW YORK, NYExec · DirectorPeter Thompson · New York, NYDirectorMona Ashiya · NEW YORK, NYDirectorCarl Gordon · CAMBRIDGE, MADirectorAsa Abeliovich · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗